Luceome Biotechnologies

Luceome Biotechnologies is a biotechnology company specializing in the development of high-throughput screening assays for drug discovery, with a primary focus on kinase profiling. The company's core technology, KinaseSeeker, utilizes a proprietary split-luciferase bioluminescence platform to enable sensitive and accurate profiling of small molecule inhibitors against a broad panel of human kinases. Luceome provides both ready-to-use assay kits and comprehensive screening services to pharmaceutical and biotechnology partners to accelerate the identification of lead compounds. Their platform is distinguished by its ability to measure binding in a displacement format without the need for radioactive materials or complex wash steps. By providing high-quality data on drug-target interactions, Luceome supports the development of targeted therapies for oncology and inflammatory conditions.